Takeshi Senjyu

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM To investigate the factors influenced the efficacy of tolvaptan (TLV) in liver cirrhosis. METHODS We retrospectively enrolled 61 consecutive patients with refractory hepatic ascites. All of them had been treated with furosemide and spironolactone before admission, and treated with TLV for 7 d in our hospital. The effect of TLV was defined by the rate(More)
  • 1